Floatz logo

NEPENTHE

Lumbar Disk Degenerative Disorder

Brigham and Women's HospitalSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

8 Active assets in the Lumbar Disk Degenerative Disorder cohort.

Asset / SponsorPhaseRating
Oxycodone
Brigham and Women's Hospital
Phase 4BB
Ibuprofen
St Joseph University, Beirut, Lebanon
Phase 4BB
Pentoxifylline
St Joseph University, Beirut, Lebanon
Phase 4BB
AUTOLOGOUS CONDITIONED PLASMA
Allmed Medical Center
Phase 2BB
Rexlemestrocel-L
Mesoblast, Ltd.
Phase 3BB

View all 14 →

Same molecule, other indications

NEPENTHE is also rated in:

cancer of unknown primary siteDormant
BBB
Indicative · Phase 4
75 / 100
View asset →
chronic pain syndromeActive
BBB
Indicative · Phase 4
74 / 100
View asset →
post-operative pain, non-human animalActive
BBB
Indicative · Phase 4
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →